Earnings summaries and quarterly performance for Trulieve Cannabis.
Executive leadership at Trulieve Cannabis.
Kim Rivers
Chief Executive Officer
Eric Powers
Chief Legal Officer and Corporate Secretary
Gina Collins
Chief Marketing Officer
Jan Reese
Chief Financial Officer
Jason Pernell
President
Joy Malivuk
Chief Accounting Officer
Kyle Landrum
Chief Production Officer
Marie Zhang
Chief Operating Officer
Nilyum Jhala
Chief Technology Officer
Timothy Morey
Chief Sales Officer
Board of directors at Trulieve Cannabis.
Research analysts who have asked questions during Trulieve Cannabis earnings calls.
Aaron Grey
Alliance Global Partners
3 questions for TCNNF
Andrew Partheniou
Stifel
3 questions for TCNNF
Matt McGinley
Needham
3 questions for TCNNF
Russell Stanley
Beacon Securities
3 questions for TCNNF
Derek Dley
Canaccord Genuity
2 questions for TCNNF
Scott Fortune
ROTH MKM
2 questions for TCNNF
Andrew Semple
Echelon Capital Markets
1 question for TCNNF
Eric DesLauriers
Craig-Hallum Capital Group
1 question for TCNNF
Eric Des Lauriers
Craig-Hallum Capital Group LLC
1 question for TCNNF
Kenric Tyghe
ATB Capital Markets
1 question for TCNNF
Pablo Zuanic
Zuanic & Associates
1 question for TCNNF
Ty Collin
Eight Capital
1 question for TCNNF
Recent press releases and 8-K filings for TCNNF.
- Trulieve Cannabis Corp. reported full year 2025 revenue of $1.2 billion and Q4 2025 revenue of $293 million, with a 60% gross margin for both periods.
- The company achieved record adjusted EBITDA of $427 million for the full year 2025, representing a 2% increase from 2024.
- Trulieve generated record cash flow from operations of $273 million and free cash flow of $229 million for the full year 2025.
- The company redeemed $368 million of senior secured notes due 2026 and closed a $140 million private placement of senior secured notes due 2030.
- Trulieve was granted conditional approval for a Dispensing Organization license under the Texas Compassionate Use Program and grew its rewards program to 915,000 members by December 31, 2025.
- Trulieve Cannabis Corp. closed a second tranche of its previously announced private placement of 10.5% Senior Secured Notes due 2030 on January 29, 2026.
- This tranche amounted to US$60.0 million, bringing the total aggregate principal amount of Notes issued to US$200.0 million.
- The net proceeds from the offering are intended for capital expenditures and other general corporate purposes.
- The Notes are direct senior secured obligations of the Company, bearing interest at 10.5% per annum payable semi-annually, and will mature on December 17, 2030.
- Trulieve Cannabis Corp. announced the closing of a private placement of 10.5% Senior Secured Notes due 2030 for aggregate gross proceeds of US$140.0 million on December 17, 2025.
- The Notes bear an annual interest rate of 10.5%, payable semi-annually, and will mature on December 17, 2030.
- The company intends to use the net proceeds from the offering for capital expenditures and other general corporate purposes.
- These Notes are direct senior secured obligations of the company, ranking senior to all existing and future unsecured indebtedness, and are secured solely by a pledge of Trulieve US shares.
- Trulieve Cannabis Corp. has received commitments for a private placement of US$100.0 million in 10.5% Senior Secured Notes due 2030.
- The Notes will bear an interest rate of 10.5% per annum, payable semi-annually, and are expected to mature on or about December 17, 2030.
- The company intends to use the net proceeds from the offering for capital expenditures and other general corporate purposes.
- The offering is expected to close on December 17, 2025.
- Trulieve Cannabis Corp. reported Q3 2025 revenue of $288 million with a 59% gross margin and adjusted EBITDA of $103 million, or 36% of revenue, which was up 7% year over year.
- The company generated cash flow from operations of $77 million and free cash flow of $64 million in Q3 2025, ending the quarter with $458 million in cash.
- Trulieve announced the planned redemption of $368 million of senior secured notes due 2026 and expects Q4 revenue to be up low single-digits compared to Q3.
- The company anticipates 2025 cash flow from operations of at least $250 million and currently operates 232 retail dispensaries.
- Jan Reese was added as Chief Financial Officer and Matthew Foulston was appointed to the Board of Directors.
Quarterly earnings call transcripts for Trulieve Cannabis.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more